Infectious disease companies develop technologies, diagnostics and therapeutics that prevent, detect and treat bacterial, viral, fungal and parasitic infections. Their work supports global health, outbreak response and disease surveillance.
This category includes companies working on:
Browse 118 UK infectious disease companies below.
ELISA kits and diagnostics for research and clinical use
JR Biomedical is a North Wales-based developer, manufacturer and distributor of diagnostic reagents and ELISA kits for research institutions, NHS laboratories and pharmaceutical companies. Operating from ISO 13485-certified laboratories at the OpTIC Centre in St Asaph, the company develops human ELISA kits across…
Biological medicines and vaccine manufacturing at Porton Down
Porton Biopharma is a government-owned biopharmaceutical company based at Porton Down, Wiltshire. It developed and manufactured biological medicines using microbial fermentation, including the UK's anthrax vaccine and Erwinase (crisantaspase), an enzyme therapy for acute lymphoblastic leukaemia. In March 2025, the…
Europe's largest biomedical discovery institute researching the biology of disease
The Francis Crick Institute is a biomedical discovery institute researching the biology underlying human health and disease. The Institute studies biology from molecules to entire organisms, translating discoveries into new ways to treat illnesses including cancer, heart disease and neurodegenerative conditions.…
Ovine polyclonal therapeutics developer and antivenom manufacturer
MicroPharm is a specialty pharmaceutical company developing and manufacturing ovine polyclonal antibody therapeutics for the treatment of acute toxic and infectious conditions. The company's MHRA-licensed facilities in West Wales produce a portfolio of clinical-grade antivenoms, including products acquired from Sanofi…
Small-molecule anti-biofilm add-on therapy for antibiotic-resistant urinary tract infections
BioTryp Therapeutics is a UK-based drug discovery company developing small-molecule therapies that inhibit bacterial biofilm formation. The company's lead programme is an oral add-on therapy designed to be used alongside existing antibiotics, targeting a bacterial protein conserved across more than 85 species to…
Oral thermostable vaccine platform for infectious diseases
iosBio is a biotechnology company developing thermostable oral vaccines using adenoviral vector delivery. Its platform protects vaccine vectors to survive stomach transit and release in the lower small intestine, inducing mucosal and systemic immunity without cold chain requirements or needle administration. The lead…
Portable multiplex PCR molecular diagnostic platform for point-of-care use
QuantuMDx is a medical technology company developing a battery-operated, handheld molecular diagnostic system that delivers multiplex PCR results from a single-use reagent cassette within 35 minutes. Designed for point-of-care and resource-limited settings, the CE-IVD marked device supports assays for respiratory…
Lateral flow and molecular diagnostic tests for multiple applications
AccuBio is a UK-based manufacturer of in-vitro diagnostic products, producing lateral flow assays and molecular diagnostic tests across infectious disease, toxicology, oncology, cardiovascular, and veterinary applications. Operating from manufacturing facilities in Alva, Scotland, acquired from Omega Diagnostics, the…
PCR-based diagnostic kits, instruments and consumables manufacturer
Advanced Molecular Diagnostics is a manufacturer of molecular diagnostic instruments, kits, and consumables for clinical and food safety applications. Its CE-IVD certified product portfolio includes real-time qPCR assay kits for infectious diseases, genetic mutations, respiratory pathogens, sexually transmitted…
Genetically engineered insects for sustainable pest and disease vector control
Flyttr is an Oxfordshire-based biotechnology company developing biological solutions for sustainable pest management. Its core technology uses genetically engineered insects carrying a self-limiting gene to suppress populations of disease-transmitting and crop-damaging pests without chemicals or harm to non-target…
Global drug discovery and development partnership company
Evotec is a global drug discovery and development company with major UK operations at Milton Park, Abingdon, and Alderley Park, Cheshire. Its Abingdon campus houses over 800 staff spanning target validation, medicinal chemistry, structural biology, in silico design, process development, and biologics manufacturing…
Microbiology CRO for antimicrobial product testing and regulatory support
BluTest Laboratories Limited is a UKAS-accredited contract research organisation providing microbiology testing and development services to manufacturers of antimicrobial products, disinfectants, and medical devices. The company offers bactericidal, fungicidal, sporicidal, and virucidal efficacy testing to EN, ASTM,…
Integrated academic drug discovery facility for anti-infectives and innovative targets
The Drug Discovery Unit is an academic drug discovery facility at the University of Dundee, integrating medicinal chemistry, high-throughput screening, structural biology, cell biology, and DMPK in a single purpose-built facility. The DDU conducts small molecule drug discovery programmes across two areas:…
Molecular controls manufacturer for infectious disease diagnostics
Qnostics is a manufacturer of molecular controls for use in molecular diagnostic laboratories and IVD product development. The company develops, manufactures and distributes a portfolio of characterised viral, bacterial and fungal reference materials for infectious disease targets, supporting assay performance…
Metal-based antimicrobial drugs and antibiofilm coating compounds
MetalloBio is a University of Sheffield spin-out developing metal-based antimicrobial compounds against drug-resistant bacterial infections. Its KLS-1 series includes investigational antibacterial candidate KLS-116, designed to act against multidrug-resistant pathogens and biofilms. The KLS-2 series is being developed…
Inhaled antifungal therapies for serious respiratory fungal infections
Pulmocide is a late-stage biopharmaceutical company developing inhaled medicines for life-threatening respiratory fungal infections. Its lead compound opelconazole is a triazole antifungal designed for inhaled delivery to maximise pulmonary drug concentration while minimising systemic exposure and drug interactions.…
Isothermal molecular diagnostics and assay development services
Simplex Molecular is a biotechnology company developing instrument-free nucleic acid testing technology alongside molecular biology research services. Its proprietary isothermal amplification chemistry operates at room temperature and is being developed into a portable, multiplexed diagnostic platform with…
World leading centre researching viral diseases of farm animals
The Pirbright Institute researches viral diseases of farm animals and viruses that spread from animals to humans. The Institute works to predict, detect and respond to livestock diseases, developing vaccines and diagnostic tests that support global food security and public health. Its high containment laboratories…
Bacteriophage antimicrobials targeting livestock pathogens to replace antibiotics
Aparon is a biotechnology company developing bacteriophage-based technologies as novel antimicrobials for use in livestock production. Its research focuses on identifying and formulating bacteriophage cocktails that selectively destroy bacterial pathogens in animals, offering an alternative to conventional antibiotic…
Immunological reagents, assay services and target-binding proteins for immune research
ProImmune is a provider of immunological reagents and assay services supporting research into adaptive immune responses. The company offers assay services to help researchers understand immune responses to vaccines and therapeutics, using ELISpot and flow cytometry techniques, alongside recombinant target-binding…